USFDA approves AbbVie giant cell arteritis drug Rinvoq in adults Ruchika Sharma30 April 2025 4:30 PM ISTNorth Chicago, Ill.: AbbVie has received approval from the U.S. Food and Drug Administration (FDA) for RINVOQ (upadacitinib), 15 mg, once daily,...
Abbvie seeks USFDA nod for trenibotulinumtoxinE for glabellar lines treatment Ruchika Sharma25 April 2025 11:46 AM ISTNorth Chicago, Ill.: AbbVie has announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for...
Abbvie CEO Robert A Michael to assume additional role of Board Chairman Ruchika Sharma18 Feb 2025 4:30 PM ISTNorth Chicago: AbbVie has announced that its board of directors has unanimously elected chief executive officer (CEO) Robert A. Michael to assume...
AbbVie gets USFDA nod for Emblaveo for treatment of adults with complicated intra abdominal infections with limited or no treatment option Ruchika Sharma8 Feb 2025 11:30 AM ISTNorth Chicago: AbbVie has announced that the U.S. Food and Drug Administration (FDA) has approved EMBLAVEO (aztreonam and avibactam), as a...
AbbVie concludes acquisition of Aliada Therapeutics Ruchika Sharma15 Dec 2024 10:00 AM ISTNorth Chicago, Ill: AbbVie has announced that it has completed its acquisition of Aliada Therapeutics. With the completion of the acquisition, Aliada...
AbbVie gets European Commission nod for Elahere for Platinum-Resistant ovarian cancer Ruchika Sharma19 Nov 2024 6:24 PM ISTNorth Chicago: AbbVie has announced the European Commission (EC) has granted marketing authorization for ELAHERE (mirvetuximab soravtansine) for...
AbbVie seeks USFDA accelerated approval for telisotuzumab vedotin for previously treated non small cell lung cancer Ruchika Sharma29 Sept 2024 1:15 PM ISTNorth Chicago: AbbVie has announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for...
AbbVie, FutureGen ink pact to develop Next-Generation Therapy for Inflammatory Bowel Disease Ruchika Sharma17 Jun 2024 12:30 PM ISTNorth Chicago, IlI.: AbbVie and FutureGen Biopharmaceutical (Beijing) Co., Ltd. have announced a license agreement to develop FG-M701, a next...
AbbVie concludes acquisition of Landos Biopharma Ruchika Sharma28 May 2024 2:30 PM ISTNorth Chicago, Ill.: AbbVie has announced that it has completed its acquisition of Landos Biopharma, Inc. With the completion of the acquisition,...
USFDA grants full approval for Abbvie Elahere for certain ovarian cancer patients Ruchika Sharma23 March 2024 1:15 PM ISTNorth Chicago, Ill.: AbbVie has announced that the U.S. Food and Drug Administration (FDA) has granted full approval for ELAHERE...
AbbVie, OSE Immunotherapeutics collaborate to develop novel monoclonal antibody for Chronic Inflammation Ruchika Sharma3 March 2024 10:00 AM ISTUnder the terms of the agreement, AbbVie will receive an exclusive global license to develop, manufacture and commercialize OSE-230.
AbbVie, Tentarix collaborate to develop conditionally-active, multi-specific biologics for oncology, immunology Ruchika Sharma25 Feb 2024 12:45 PM ISTNorth Chicago: AbbVie Inc. and Tentarix Biotherapeutics have announced a multi-year collaboration focused on the discovery and development of...
